Ligand profile
CHEMBL5416840
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_04217 — Thioredoxin reductase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL5416840- UniProt (similar protein)
P0A9P4- pchembl
- 6.160 (~691.8 nM)
- Target protein
- KP13_04217
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 35.6
- −1 ≤ LogP ≤ 5 3.48
- MW ≤ 500 Da 473.2
- LogP ≤ 5 3.48
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 35.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1nn(CC[Se][Se]CCn2nc(C)c(Cl)c2C)c(C)c1ClCc1nn(CC[Se][Se]CCn2nc(C)c(Cl)c2C)c(C)c1Cl
InChI=1S/C14H20Cl2N4Se2/c1-9-13(15)11(3)19(17-9)5-7-21-22-8-6-20-12(4)14(16)10(2)18-20/h5-8H2,1-4H3InChI=1S/C14H20Cl2N4Se2/c1-9-13(15)11(3)19(17-9)5-7-21-22-8-6-20-12(4)14(16)10(2)18-20/h5-8H2,1-4H3
QLWXHLJGLMMPMM-UHFFFAOYSA-NQLWXHLJGLMMPMM-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- ChEMBL
- Binding sites
- PF07992
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL5416840 →
- UniProt UniProt P0A9P4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL5416840”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04217.
PDB 5
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 15
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).